Systematic medical assessment, referral and treatment for diabetes care in China using lay family health promoters: protocol for the SMARTDiabetes cluster randomised controlled trial

BACKGROUND: Type 2 diabetes (T2DM) affects 113.9 million people in China, the largest number of any country in the world (JAMA 310:948–59, 2013). T2DM prevalence has risen dramatically from around 1 % in the 1980s to now over 10 % and is expected to continue rising. Despite the growing disease burde...

Descripción completa

Detalles Bibliográficos
Autores principales: Peiris, David, Sun, Lei, Patel, Anushka, Tian, Maoyi, Essue, Beverley, Jan, Stephen, Zhang, Puhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989287/
https://www.ncbi.nlm.nih.gov/pubmed/27535128
http://dx.doi.org/10.1186/s13012-016-0481-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989287/
https://www.ncbi.nlm.nih.gov/pubmed/27535128
http://dx.doi.org/10.1186/s13012-016-0481-8

Ejemplares similares